Cargando…

Survival post surgery for malignant pericardial effusion

The study reviews the survival of patients with malignant pericardial effusion treated with a subxiphoid pericardial window. The medical records of 60 consecutive patients diagnosed with a malignant pericardial effusion and treated with a subxiphoid pericardial window between 1994 and 2008 were revi...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Olivier, Ouellette, Denise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3981241/
https://www.ncbi.nlm.nih.gov/pubmed/24765299
http://dx.doi.org/10.4081/cp.2011.e38
_version_ 1782311003520761856
author Nguyen, Olivier
Ouellette, Denise
author_facet Nguyen, Olivier
Ouellette, Denise
author_sort Nguyen, Olivier
collection PubMed
description The study reviews the survival of patients with malignant pericardial effusion treated with a subxiphoid pericardial window. The medical records of 60 consecutive patients diagnosed with a malignant pericardial effusion and treated with a subxiphoid pericardial window between 1994 and 2008 were reviewed. 72% had lung cancer. Overall 30-day mortality was 31%. Survival rates at 3 months, 6 months, 1 year, and 2 years were 45%, 28%, 17%, and 9%, respectively. Overall median survival was 2.6 months. Patients with malignant pericardial effusion, especially those with primary lung cancer have poor survival rates. In advanced malignancy, the subxiphoid pericardial window procedure provides only short-term palliation of symptoms, and has no effect on long-term survival. The use of any surgical procedure in patients with malignant advanced pericardial effusion should be considered along with non-surgical options on a case-by-case basis depending on symptoms, general status, and expected survival.
format Online
Article
Text
id pubmed-3981241
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher PAGEPress Publications
record_format MEDLINE/PubMed
spelling pubmed-39812412014-04-24 Survival post surgery for malignant pericardial effusion Nguyen, Olivier Ouellette, Denise Clin Pract Case Report The study reviews the survival of patients with malignant pericardial effusion treated with a subxiphoid pericardial window. The medical records of 60 consecutive patients diagnosed with a malignant pericardial effusion and treated with a subxiphoid pericardial window between 1994 and 2008 were reviewed. 72% had lung cancer. Overall 30-day mortality was 31%. Survival rates at 3 months, 6 months, 1 year, and 2 years were 45%, 28%, 17%, and 9%, respectively. Overall median survival was 2.6 months. Patients with malignant pericardial effusion, especially those with primary lung cancer have poor survival rates. In advanced malignancy, the subxiphoid pericardial window procedure provides only short-term palliation of symptoms, and has no effect on long-term survival. The use of any surgical procedure in patients with malignant advanced pericardial effusion should be considered along with non-surgical options on a case-by-case basis depending on symptoms, general status, and expected survival. PAGEPress Publications 2011-05-30 /pmc/articles/PMC3981241/ /pubmed/24765299 http://dx.doi.org/10.4081/cp.2011.e38 Text en ©Copyright A. Minisini et al., 2011 This work is licensed under a Creative Commons Attribution 3.0 License (by-nc 3.0). Licensee PAGEPress, Italy
spellingShingle Case Report
Nguyen, Olivier
Ouellette, Denise
Survival post surgery for malignant pericardial effusion
title Survival post surgery for malignant pericardial effusion
title_full Survival post surgery for malignant pericardial effusion
title_fullStr Survival post surgery for malignant pericardial effusion
title_full_unstemmed Survival post surgery for malignant pericardial effusion
title_short Survival post surgery for malignant pericardial effusion
title_sort survival post surgery for malignant pericardial effusion
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3981241/
https://www.ncbi.nlm.nih.gov/pubmed/24765299
http://dx.doi.org/10.4081/cp.2011.e38
work_keys_str_mv AT nguyenolivier survivalpostsurgeryformalignantpericardialeffusion
AT ouellettedenise survivalpostsurgeryformalignantpericardialeffusion